Immunosuppression in systemic lupus erythematosus. Effect of cyclophosphamide and corticoids on lymphocyte subpopulations
Fuks, A.; Carballal, G.; Manni, J.A.
Medicina 39(3): 289-297
1979
ISSN/ISBN: 0025-7680 PMID: 514050 Document Number: 142584
Document emailed within 1 workday
Related Documents
Ljaljević, M.; Ljaljević, J.; Kunosić, J.; Zlatković, L. 1985: The level of the T lymphocyte and B lymphocyte subpopulations in patients with systemic lupus erythematosus Glas. Srpska Akademija Nauka i Umetnosti. Odeljenje Medicinskih Nauka 37: 131-139Dubois, E.L.; Chandor, S.; Friou, G.J.; Bischel, M. 1971: Progressive systemic sclerosis and localized scleroderma morphea with positive lupus erythematosus cell test and unusual systemic manifestations compatible with systemic lupus erythematosus presentation of 14 cases including 1 set of identical twins 1 with scleroderma and the other with systemic lupus erythematosus review of the literature Medicine (Baltimore) 50(3): 199-222
Carr, R.; Forsyth, S.; Sadi, D. 1987: Abnormal responses to ingested substances in murine systemic lupus erythematosus: apparent effect of a casein-free diet on the development of systemic lupus erythematosus in NZB/W mice Journal of Rheumatology. Suppl 14(Suppl 13): 158-165
Rodeck, U.; Kreuzfelder, E.; Kuwert, E.; Rupprecht, H.J.; Brittinger, G.; Laubenthal, F. 1983: Double-stranded DNA antibodies and lymphocyte subpopulations in disseminated lupus erythematosus Die Medizinische Welt 34(24): 692-693
Ichikawa, Y.; Yamada, H.; Tanaka, H.; Yoshida, T. 1994: Cyclophosphamide pulse therapy in systemic lupus erythematosus Ryumachi 34(3): 675-683
Mittal, G.; Balakrishnan, C.; Mangat, G.; Joshi, V.R. 1999: High dose cyclophosphamide in the treatment of systemic lupus erythematosus Journal of the Association of Physicians of India 47(7): 747
Anić, B.; Crkvencić, N.; Mayer, M.; Bosnić, D.; Sentić, M.; Markeljević, J.; Cikes, N. 1999: Intermittent intravenous cyclophosphamide application in patients with systemic lupus erythematosus Lijecnicki Vjesnik 121(9-10): 283-288
Groen, H.; Bootsma, H.; Postma, D.S.; Kallenberg, C.G. 1993: Primary pulmonary hypertension in a patient with systemic lupus erythematosus: partial improvement with cyclophosphamide Journal of Rheumatology 20(6): 1055-1057
Yang, X.; Yin, P.; Gao, X. 1996: A study on interval of intravenous cyclophosphamide pulse in the treatment of severe systemic lupus erythematosus Zhonghua Nei Ke Za Zhi 35(4): 257-260
Aikawa, N.E.; Sallum, A.M.E.; Pereira, R.M.R.; Suzuki, L.; Viana, V.S.T.; Bonfá, E.; Silva, C.A. 2012: Subclinical impairment of ovarian reserve in juvenile systemic lupus erythematosus after cyclophosphamide therapy Clinical and Experimental Rheumatology 30(3): 445-449
Yang, X.-y.; Zhu, X.; Liang, L.-q.; Zhan, Z.-p.; Ye, Y.-j. 2005: Risk factors of ovarian failure in the patients with systemic lupus erythematosus receiving cyclophosphamide therapy Zhonghua Yi Xue Za Zhi 85(14): 960-962
Miyoshi, Y.; Kilpatrick, K.A.; Kelley, R.O.; Searles, R.P.; Williams, R.C. 1985: Antibodies to lymphocyte membrane preparations in systemic lupus erythematosus Journal of Rheumatology 12(6): 1097-1104
Hara, M. 1977: Clinical significance of the lymphocyte function in systemic lupus erythematosus Ryumachi 17(1): 6-16
Leung, F.K.; Fortin, P.R. 2003: Intravenous cyclophosphamide and high dose corticosteroids improve MRi lesions in demyelinating syndrome in systemic lupus erythematosus Journal of Rheumatology 30(8): 1871-1873
Bi, L.Q.; Song, Y.; Sun, R.W. 1990: Lymphocyte phenotypes and their correlation with clinical features in systemic lupus erythematosus (SLE) Zhonghua Nei Ke Za Zhi 29(12): 720
Bach, J.F.; Viard, J.P. 1990: Hypothesis: systemic lupus erythematosus as a disease secondary to polyclonal lymphocyte activation Clinical and Experimental Rheumatology 8(Suppl 5): 57-64
Becker, H.; Schauer, U.; Helmke, K. 1986: B lymphocyte activation by insoluble anti-mu antibodies in patients with systemic lupus erythematosus Clinical and Experimental Immunology 66(2): 365-372
Petri, M. 1998: The effect of race on incidence and clinical course in systemic lupus erythematosus: the Hopkins Lupus Cohort Journal of the American Medical Women's Association 53(1): 9-12
Winfield, J.B.; Shaw, M.; Minota, S. 1986: Modulation of IgM anti-lymphocyte antibody-reactive T cell surface antigens in systemic lupus erythematosus Journal of Immunology 136(9): 3246-3253
Drannik, G.N.; Lysenko, G.I.; Montag, T.S.; Kozlovskaia, I.N.; Litvishchenko, E.I. 1980: Functional activity of nonspecific T-lymphocyte suppressors in health persons and in systemic lupus erythematosus patients Vrachebnoe Delo 1: 88-90